Parkinson Disease/ Parkinsonian Disorders

Contributing journals to this collection:
JAMA & Archives Journals

Citations 51-60 of 407 total displayed.

Past content

Neurological Reviews
There Is No Parkinson Disease

William J. Weiner
Arch Neurol 2008; 65: 705-708. [Abstract] [Full text] [PDF]  

Clinical Trials
Serum Urate as a Predictor of Clinical and Radiographic Progression in Parkinson Disease

Michael A. Schwarzschild; Steven R. Schwid; Kenneth Marek; Arthur Watts; Anthony E. Lang; David Oakes; Ira Shoulson; Alberto Ascherio; and the Parkinson Study Group PRECEPT Investigators
Arch Neurol 2008; 65: 716-723. [Abstract] [Full text] [PDF]  

Original Contributions
Mutation Analysis of the PINK1 Gene in 391 Patients With Parkinson Disease

Ryuya Kumazawa; Hiroyuki Tomiyama; Yuanzhe Li; Yoko Imamichi; Manabu Funayama; Hiroyo Yoshino; Fusako Yokochi; Toshihiro Fukusako; Yasushi Takehisa; Kenichi Kashihara; Tomoyoshi Kondo; Bulent Elibol; Sevasti Bostantjopoulou; Tatsushi Toda; Hirohide Takahashi; Fumihito Yoshii; Yoshikuni Mizuno; Nobutaka Hattori
Arch Neurol 2008; 65: 802-808. [Abstract] [Full text] [PDF]  

Images in Neurology
Postencephalitic Hemiparkinsonism: Clinical Imaging Correlation

Hen Hallevi; Irene J. Oh; Sherley R. Valdez; Benjamin G. Kidder; Mya C. Schiess
Arch Neurol 2008; 65: 837. [Extract] [Full text] [PDF]  

Correspondence
The Need for Appropriate Genotyping Strategies for Glucocerebrosidase Mutations in Cohorts With Parkinson Disease

Usha Gutti; Hon-Chung Fung; Kathleen S. Hruska; Mary E. LaMarca; Chiung-Mei Chen; Yih-Ru Wu; Ellen Sidransky
Arch Neurol 2008; 65: 850-851. [Extract] [Full text] [PDF]  

Correspondence
The Need for Appropriate Genotyping Strategies for Glucocerebrosidase Mutations in Cohorts With Parkinson Disease—Reply

Eng-King Tan
Arch Neurol 2008; 65: 851. [Extract] [Full text] [PDF]  

The World in Medicine
Parkinson Disease

Joan Stephenson
JAMA 2008; 299: 2267-b. [Extract] [Full text] [PDF]  

Clinical Trials
Tesofensine (NS 2330), a Monoamine Reuptake Inhibitor, in Patients With Advanced Parkinson Disease and Motor Fluctuations: The ADVANS Study

Olivier Rascol; Werner Poewe; Andrew Lees; Marina Aristin; Laurence Salin; Nolwenn Juhel; Lisa Waldhauser; Thomas Schindler; for the ADVANS Study Group
Arch Neurol 2008; 65: 577-583. [Abstract] [Full text] [PDF]  

Original Contributions
Improvement in Parkinson Disease by Subthalamic Nucleus Stimulation Based on Electrode Placement: Effects of Reimplantation

Mathieu Anheim; Alina Batir; Valérie Fraix; Madjid Silem; Stéphan Chabardès; Eric Seigneuret; Paul Krack; Alim-Louis Benabid; Pierre Pollak
Arch Neurol 2008; 65: 612-616. [Abstract] [Full text] [PDF]  

Clinical Trials
Serum Urate as a Predictor of Clinical and Radiographic Progression in Parkinson Disease

Michael A. Schwarzschild; Steven R. Schwid; Kenneth Marek; Arthur Watts; Anthony E. Lang; David Oakes; Ira Shoulson; Alberto Ascherio; and the Parkinson Study Group PRECEPT Investigators
Arch Neurol 2008.65.6.nct70003. [Abstract] [Full text] [PDF]  

[First page]   [Previous page]   [Next page] Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41